Insights

What Can Pharma Expect in 2019?


Read the article

2018 was a transformative year for life sciences companies. Many of them worked toward getting closer to patients, embracing real-world evidence and adopting more digital technologies to make their work more efficient.

So what does 2019 hold for life sciences companies? Is it going to be the year that AI makes its mark on the industry? Will providing value-based care to patients take center stage? In this eyeforpharma article, ZS’s Aaron Mitchell and other industry experts discuss what we can expect in 2019 when it comes to drug pricing and healthcare affordability, leveraging data and analytics to deliver value-based healthcare, the uses of artificial intelligence and more.